Journals RSS : Gourt http://www.gourt.com/Health/Medicine/Medical-Specialties/Gastroenterology/Journals.html en-us Copyright 2007, Gourt.com 2009-07-02T18:32+39:00 rtruog@gourt.com rtruog@gourt.com Journals RSS : Gourt hourly 1 1901-01-01T00:00+00:00 Optical coherence tomography in children with coeliac disease http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1590865809002448&_version=1&md5=e5494ec870c718115a59c4861306be4b The complexities of hepatitis C virus entry? http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S0168827809004553&_version=1&md5=cc94d074f800586887ff3345f003c025 Forewarned is forearmed? http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S0168827809004528&_version=1&md5=712458fc4564793e80d5ff0d34e83f0a Infection and inflammation in liver failure: Two sides of the same coin? http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S0168827809004516&_version=1&md5=2ae0f8162b096f1a731c65e731a4b6ee Coronary artery disease in liver cirrhosis: Does the aetiology of liver disease matter? http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S0168827809004504&_version=1&md5=016958384993f7f79f8da3eb09bc1d10 Reactivation of Hepatitis B with Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immune Suppression http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509006004&_version=1&md5=2276f6880c4e3eaf2785078f19ee558a International Consensus Guidelines for Surgical Resection of Mucinous Neoplasms Cannot Be Applied to All Cystic Lesions of the Pancreas http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509005990&_version=1&md5=3d0e65146b144c7e866986a2609abf79 A systematic prospective comparison of non-invasive disease activity indices in ulcerative colitis http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509005977&_version=1&md5=7feacbd79bf7f30d571461bf098c0be0 A 38 year old with recurrent colitis. Is it noncompliance? http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509005953&_version=1&md5=da3880fc1d8b31b78726e0f71d570c58 Response to Lankisch et al http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S154235650900593X&_version=1&md5=8060e5f39c3cb5e7eb15616e4a30bf63 A randomized controlled trial of enemas in combination with oral laxative therapy for children with chronic constipation http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509005916&_version=1&md5=f95e76ebe35827ac6cec96d07a8b6131 Copyright Assignment, Authorship Responsibility, NIH Funding, Financial Disclosure, Institutional Review Board/Animal Care Committee Approval, and Sponsorship http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509004947&_version=1&md5=9fa50d7a855ab96def037195b4937cd2 Information for Authors http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509004959&_version=1&md5=120501cab97ef44558b075ced6f27739 Epidemiology of Eosinophilic Esophagitis over 3 Decades in Olmsted County, Minnesota http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509005965&_version=1&md5=0bc9e4485021065acacd6ffa3de98ead Information for Authors and Readers http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509004935&_version=1&md5=769b2f6a4fcf200f863cc5f362f0d59e Grievous Disease http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509005928&_version=1&md5=64a22bd7b634cb4902f5b76d176ac839 The Impact of Narrow Band Imaging in Screening Colonoscopy: A Randomized Controlled Trial http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509006016&_version=1&md5=3d5e4282d7ee814559d6f8eb8ac93f3a Contents http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509004923&_version=1&md5=badb42a84842a5a0aa3a92e2d9134224 Editorial Board http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509004911&_version=1&md5=f08fce2af0542aa57f4dcb4a6973b689 Do We Know What Patients Want? The Doctor-Patient communication gap in Functional Gastrointestinal Disorders http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_method=citationSearch&_piikey=S1542356509005989&_version=1&md5=9b54ad6eee21a0cb277085cb92a4220e Reply: Persistent Nausea and Abdominal Pain in a Patient with Delayed Gastric Emptying: Shall We Think of Celiac Disease? http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=19563914&dopt=Abstract Reply: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=19563913&dopt=Abstract Keep your cool: burn calories http://dx.doi.org/10.1038/nrgastro.2009.88 Ulcerative colitis: Appendicitis, but not appendectomy, reduces risk of ulcerative colitis http://dx.doi.org/10.1038/nrgastro.2009.78 IBD: Diagnosis by proteasome pattern http://dx.doi.org/10.1038/nrgastro.2009.74 Esophageal cancer: Hot tea raises risk of cancer http://dx.doi.org/10.1038/nrgastro.2009.79 Prediction of recurrent C. difficile infection http://dx.doi.org/10.1038/nrgastro.2009.73 Liver: Dietary links to NAFLD in nonobese patients http://dx.doi.org/10.1038/nrgastro.2009.75 Gastrointestinal stromal tumor: Adjuvant imatinib mesylate therapy improves recurrence-free survival http://dx.doi.org/10.1038/nrgastro.2009.80 Pancreas: Alcoholic pancreatitis—it's the alcohol, stupid http://dx.doi.org/10.1038/nrgastro.2009.84 Rectal cancer: The evolution of laparoscopy—what's next? http://dx.doi.org/10.1038/nrgastro.2009.82 Motility: Prucalopride for chronic constipation http://dx.doi.org/10.1038/nrgastro.2009.81 Hepatitis C: New therapeutic strategies needed for advanced disease http://dx.doi.org/10.1038/nrgastro.2009.63 Surgery: Neoadjuvant chemoradiation and sphincter preservation http://dx.doi.org/10.1038/nrgastro.2009.83 Management of gastric polyps: a pathology-based guide for gastroenterologists http://dx.doi.org/10.1038/nrgastro.2009.70 Actions and therapeutic pathways of ghrelin for gastrointestinal disorders http://dx.doi.org/10.1038/nrgastro.2009.72 Capsule endoscopy: progress update and challenges ahead http://dx.doi.org/10.1038/nrgastro.2009.69 A guide for the diagnosis and management of gastrointestinal stromal cell tumors http://dx.doi.org/10.1038/nrgastro.2009.43 Treatment of chronic hepatitis C in a slow responder: a case for extended therapy http://dx.doi.org/10.1038/nrgastro.2009.65 Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model http://dx.doi.org/10.1002%2Fibd.21031 Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis http://dx.doi.org/10.1002%2Fibd.21029 Quality of care in inflammatory bowel disease: A review and discussion http://dx.doi.org/10.1002%2Fibd.21028 Sterile seroma after surgical drainage of purulent psoas abscess in Crohn's disease http://dx.doi.org/10.1002%2Fibd.21020 Potential for amino acids supplementation during inflammatory bowel diseases http://dx.doi.org/10.1002%2Fibd.21017 MDP-Induced selective tolerance to TLR4 ligands: Impairment in NOD2 mutant Crohn's disease patients http://dx.doi.org/10.1002%2Fibd.21013 Circulating midkine in Crohn's disease: Clinical implications http://dx.doi.org/10.1002%2Fibd.21011 Overall and cause-specific mortality in Crohn's disease: A meta-analysis of population-based studies http://dx.doi.org/10.1002%2Fibd.21007 Genetic dissection of granulomatous enterocolitis and arthritis in the intramural peptidoglycan-polysaccharide-treated rat model of IBD http://dx.doi.org/10.1002%2Fibd.21018 Disability in IBD: The devil is in the details http://dx.doi.org/10.1002%2Fibd.21014 Endoscopy and MR enteroclysis: Equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection http://dx.doi.org/10.1002%2Fibd.21003 Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis http://dx.doi.org/10.1002%2Fibd.20993 Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease http://dx.doi.org/10.1002%2Fibd.20985 Defining clinical criteria for clinical remission and disease activity in collagenous colitis http://dx.doi.org/10.1002%2Fibd.20977 Efficacy of oral tacrolimus on intestinal Behcet's disease http://dx.doi.org/10.1002%2Fibd.20970 Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of [gamma][delta]T and regulatory T cells of intestinal intraepithelial lymphocytes http://dx.doi.org/10.1002%2Fibd.20961 Magnifying colonoscopy used to predict disease relapse in patients with quiescent ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20949 Pityrosporum folliculitis in a Crohn's disease patient receiving infliximab http://dx.doi.org/10.1002%2Fibd.20928 Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany http://dx.doi.org/10.1002%2Fibd.20989 Strategies to improve quality of life in adolescents with inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20919 Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, c-reactive protein, and blood leukocytes http://dx.doi.org/10.1002%2Fibd.20986 Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawal http://dx.doi.org/10.1002%2Fibd.20981 Quality of web-based information on inflammatory bowel diseases http://dx.doi.org/10.1002%2Fibd.20976 0.05) than institutional, pharmaceutical, and nonpharmaceutical commercial sites. There was no relation between a rating score and the position of a website on the search engine ranking. The median Flesch Reading Ease Score was 41.65 (range, 2.6-77.7) and 11.85 (range, 6.2-21.1) for the Flesch-Kincaid Grade Level.The quality of websites containing information on IBD varies widely. Most of the online material available is too difficult to comprehend for a substantial portion of the patient population, and good quality information may be beyond reach of the average information seeker. Inflamm Bowel Dis 2009]]> Durability of infliximab in Crohn's disease: A single-center experience http://dx.doi.org/10.1002%2Fibd.20974 Targeting TNF in postoperative recurrence of Crohn's disease: Can we extinguish the fire before it starts? http://dx.doi.org/10.1002%2Fibd.20973 Role of diet in the development of inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20968 Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease http://dx.doi.org/10.1002%2Fibd.20967 Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant http://dx.doi.org/10.1002%2Fibd.20966 Infliximab for postsurgical endoscopic recurrence of Crohn's disease: No trumpets yet http://dx.doi.org/10.1002%2Fibd.20965 Thyroid disorders and inflammatory bowel diseases: Retrospective evaluation of 909 patients from an Italian Referral Center http://dx.doi.org/10.1002%2Fibd.20964 PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20963 Adalimumab-induced psoriasis of the scalp with diffuse alopecia: A severe potentially irreversible cutaneous side effect of TNF-alpha blockers http://dx.doi.org/10.1002%2Fibd.20954 Role of TNF receptors, TNFR1 and TNFR2, in dextran sodium sulfate-induced colitis http://dx.doi.org/10.1002%2Fibd.20951 Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders http://dx.doi.org/10.1002%2Fibd.20946 Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics http://dx.doi.org/10.1002%2Fibd.20943 Is it time for increased pap performance? Cervical cancer and pap testing in women with inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20987 Barriers to adherence among adolescents with inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20988 Clustering in time of familial IBD separates ulcerative colitis from Crohn's disease http://dx.doi.org/10.1002%2Fibd.20978 Solitary rectal ulcer syndrome in association with ulcerative colitis: A case report http://dx.doi.org/10.1002%2Fibd.20971 Adalimumab safety in global clinical trials of patients with Crohn's disease http://dx.doi.org/10.1002%2Fibd.20956 10 years of clinical observation. No new safety signals were identified. (Inflamm Bowel Dis 2009)]]> Pediatric Crohn's disease activity at diagnosis, its influence on pediatrician's prescribing behavior, and clinical outcome 5 years later http://dx.doi.org/10.1002%2Fibd.20950 Stress in the ER leads to inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20969 Low bone mineral density in children and adolescents with inflammatory bowel disease: A population-based study from western Sweden http://dx.doi.org/10.1002%2Fibd.20962 Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis http://dx.doi.org/10.1002%2Fibd.20960 Adalimumab as therapy for fistulizing orofacial Crohn's disease http://dx.doi.org/10.1002%2Fibd.20958 Cervical neoplasia risk in IBD: Truth or hysteria? http://dx.doi.org/10.1002%2Fibd.20957 Physicians may inadequately address Sexuality in women with inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20955 Clostridium difficile-associated diarrhea in Crohn's disease patients with Ostomy http://dx.doi.org/10.1002%2Fibd.20953 Severity of postoperative recurrence in crohn's disease: Correlation between endoscopic and sonographic findings http://dx.doi.org/10.1002%2Fibd.20948 3 mm), bowel dilation (>25 mm) or stricture (<10 mm).Ileocolonoscopy detected recurrence in 67/72 (93%) patients. SICUS detected findings compatible with recurrence in 62/72 (86%) patients (5 false negative (FN), 4 false positive (FP), 1 true negative (TN), 62 true positive (TP)), showing a 92.5% sensitivity, 20% specificity, and 87.5% accuracy for detecting CD recurrence. The BWT detected by SICUS was correlated with the Rutgeerts' score (P = 0.0001; r = 0.67). The median BWT, the extent of the ileal lesions, and the prestenotic dilation were higher in patients with an endoscopic degree of recurrence [ge]3 versus [le]2 (P < 0.001) and the lumen diameter was lower in patients with a Rutgeerts' score [ge]3 versus [le]2 (P < 0.0001).Although SICUS and ileocolonoscopy provide different views of the small bowel, SICUS shows a significant correlation with the endoscopic findings. SICUS may represent an alternative noninvasive technique for assessing CD recurrence after ileocolonic resection. (Inflamm Bowel Dis 2009)]]> Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients http://dx.doi.org/10.1002%2Fibd.20947 Musculoskeletal manifestations of inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20942 Immunizations in patients with inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20941 Resource use and societal costs for Crohn's disease in Sweden http://dx.doi.org/10.1002%2Fibd.20939 Adipokine signaling in inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20937 Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20926 0.4). Carriage of 1 or more null-alleles in patients with atopy (present in 52% of IBD patients) differed from IBD patients without atopy (14% versus 6%, P = 0.01; odds ratio [OR] 2.4, 95% confidence interval [CI] 1.2-5.1). The effect of FLG null-alleles was strongest for eczema (19% versus 7%, P = 0.0003; OR 3.3, 95% CI 1.7-6.6) and food allergy (28% versus 8%, P = 0.0001; OR 4.5, 95% CI 2.0-10.0). The presence of more than 1 atopic disease tended to increase the associated OR: eczema + asthma (23% versus 7%, P = 0.001; OR 3.9, 95% CI 1.6-9.1), eczema + asthma + allergic rhinitis (29% versus 7%, P = 0.0006; OR 5.4, 95% CI 1.9-15.4) and eczema + asthma + allergic rhinitis + food allergy (45% versus 6%, P < 10-4; OR 12.2, 95% CI 3.2-46.3). Logistic regression analysis of IBD cases confirmed the association of carriage of an FLG null-allele with atopy (P = 0.01; OR 2.4, 95% CI 1.2-5.1) and co-occurrence of different forms of atopy (P = 0.003; OR 3.5, 95% CI 1.5-8.1).Filaggrin null-alleles have no effect on IBD susceptibility but contribute to coexistent eczema and food allergy. (Inflamm Bowel Dis 2009)]]> Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement http://dx.doi.org/10.1002%2Fibd.20925 10 g/dL were prescribed oral ferrous sulfate. If hemoglobin <10 g/dL, intravenous (sucrose) iron was administered. Oral iron-intolerant patients were changed to intravenous treatment. Clinical (Truelove/Harvey-Bradshaw), hematological (response defined as hemoglobin normalization), and quality-of-life (shortened CCVEII-9 questionnaire) evaluations were performed at baseline and at 3 and 6 months.100 IBD patients (59 Crohn's disease, 41 ulcerative colitis) were included. Mean basal hemoglobin levels were 10.8 ± 1.3 g/dL (range, 6.6-12.9). Seventy-eight patients received oral treatment and 22 intravenous iron. Hemoglobin normalization was achieved in 86% of patients: 89% with oral, and 77% with intravenous iron. An IBD activity increase was not demonstrated in any patient. Four patients (5.1%) showed oral iron intolerance leading to discontinuation of treatment. No adverse events were reported for intravenous iron. Hemoglobin correlated with CCVEII-9 (P < 0.001). The CCVEII-9 score increased in patients who normalized hemoglobin levels in 3 months (from 58 ± 9 to 73 ± 10) or 6 months (54 ± 9, 68 ± 12, and 74 ± 10) (P < 0.001).Oral iron treatment is effective and well tolerated in most IBD patients, and does not exacerbate the symptoms of the underlying IBD. Intravenous iron, on the other hand, is an effective and safe alternative treatment for iron deficiency anemia in more severely anemic or intolerant patients. Anemia correction with iron treatment is associated with a relevant improvement in the patients' quality of life. (Inflamm Bowel Dis 2009)]]> Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab http://dx.doi.org/10.1002%2Fibd.20924 Varicella pneumonia in an immunocompromised inflammatory bowel disease patient http://dx.doi.org/10.1002%2Fibd.20980 Obestatin/ghrelin ratio: A new activity index in inflammatory bowel diseases http://dx.doi.org/10.1002%2Fibd.20940 Probiotics and their derivatives as treatments for inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20938 Bacteria-free solution derived from lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function http://dx.doi.org/10.1002%2Fibd.20930 Prepouch ileitis, myth or reality? The first case with acute abdomen http://dx.doi.org/10.1002%2Fibd.20929 Women with inflammatory bowel disease may infrequently rely on their physicians as a source of disease-specific information http://dx.doi.org/10.1002%2Fibd.20871 Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20920 Volvulus of an ileal J-pouch http://dx.doi.org/10.1002%2Fibd.20911 Differential expression of leukocyte functions associated antigen-1 (LFA-1) on peripheral blood mononuclear cells in patients with Crohn's disease http://dx.doi.org/10.1002%2Fibd.20935 Retinoic acid contributes to the induction of IL-12-hypoproducing dendritic cells http://dx.doi.org/10.1002%2Fibd.20934 Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease http://dx.doi.org/10.1002%2Fibd.20927 Predictive value and clinical significance of myenteric plexitis in Crohn's disease http://dx.doi.org/10.1002%2Fibd.20932 3,3[prime]-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice http://dx.doi.org/10.1002%2Fibd.20917 Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans http://dx.doi.org/10.1002%2Fibd.20921 Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20923 Established genetic risk factors do not distinguish early and later onset Crohn's disease http://dx.doi.org/10.1002%2Fibd.20922 Increased number and activation of colonic macrophages in pediatric patients with untreated Crohn's disease http://dx.doi.org/10.1002%2Fibd.20916 Ulcerative colitis and primary sclerosing cholangitis as part of autoimmune polyglandular syndrome type III http://dx.doi.org/10.1002%2Fibd.20913 Chronic granulomatous disease http://dx.doi.org/10.1002%2Fibd.20912 Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation http://dx.doi.org/10.1002%2Fibd.20910 Management and prevention of postoperative Crohn's disease http://dx.doi.org/10.1002%2Fibd.20909 Blockage of the neurokinin 1 receptor and capsaicin-induced ablation of the enteric afferent nerves protect SCID mice against T-cell-induced chronic colitis http://dx.doi.org/10.1002%2Fibd.20902 Positioning biologic agents in the treatment of Crohn's disease http://dx.doi.org/10.1002%2Fibd.20918 Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI): What difference does it make? http://dx.doi.org/10.1002%2Fibd.20906 Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse http://dx.doi.org/10.1002%2Fibd.20933 Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease http://dx.doi.org/10.1002%2Fibd.20931 Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: A prospective pilot study http://dx.doi.org/10.1002%2Fibd.20915 Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice http://dx.doi.org/10.1002%2Fibd.20908 Likelihood ratio for Crohn's disease as a function of Anti-Saccharomyces cerevisiae antibody concentration http://dx.doi.org/10.1002%2Fibd.20905 Minimally invasive total proctocolectomy with Brooke ileostomy for ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20914 Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease http://dx.doi.org/10.1002%2Fibd.20907 Gastroenterologists' prescribing of infliximab for Crohn's disease: A national survey http://dx.doi.org/10.1002%2Fibd.20904 Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a swiss cohort http://dx.doi.org/10.1002%2Fibd.20892 Inflammatory bowel disease: A paradigm for the link between coagulation and inflammation http://dx.doi.org/10.1002%2Fibd.20896 Low counts of Faecalibacterium prausnitzii in colitis microbiota http://dx.doi.org/10.1002%2Fibd.20903 Crohn's disease in a southern European country: Montreal classification and clinical activity http://dx.doi.org/10.1002%2Fibd.20901 Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: A critical systematic review http://dx.doi.org/10.1002%2Fibd.20899 Inflammatory bowel disease in the setting of autoimmune pancreatitis http://dx.doi.org/10.1002%2Fibd.20898 Risk factors and characteristics of extent progression in ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20897 FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease http://dx.doi.org/10.1002%2Fibd.20895 T and -110 G>A) for association with PA in Spanish CD patients that were recruited from a single center and followed for at least 4 years (mean follow-up time, 11 years).Results: Among the 342 CD patients evaluated, there were 88 cases of peripheral arthropathy; 31 were classified as arthritis and 57 were classified as arthralgia. We used contingency tables and logistic regression to test for association between PA or either subtype and FcRL3 and other factors that have previously been associated with extraintestinal manifestations in CD.Conclusions: We found that female sex, colonic involvement, and the AA genotype at -110 G>A were associated with increased risk of both subtypes of PA, although the association appears to be stronger for arthritis than for arthralgia.(Inflamm Bowel Dis 2009)]]> Digging out Crohn's disease genes http://dx.doi.org/10.1002%2Fibd.20889 CD68 expression is markedly different in Crohn's disease and the colitis associated with chronic granulomatous disease http://dx.doi.org/10.1002%2Fibd.20890 More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis http://dx.doi.org/10.1002%2Fibd.20886 Honey, I shrunk the telomere: UC speeds aging http://dx.doi.org/10.1002%2Fibd.20887 Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease http://dx.doi.org/10.1002%2Fibd.20866 Big risk, small risk: Small bowel cancer in Crohn's disease http://dx.doi.org/10.1002%2Fibd.20888 In flux on infliximab: Conflicting studies on surgical outcomes http://dx.doi.org/10.1002%2Fibd.20891 Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20883 Intestinal Behçet's disease: Maintenance of remission with adalimumab monotherapy http://dx.doi.org/10.1002%2Fibd.20869 Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20884 Surgical treatment of complex enterocutaneous fistulas in IBD patients using human acellular dermal matrix http://dx.doi.org/10.1002%2Fibd.20882 Peripheral neuropathy with infliximab therapy in inflammatory bowel disease http://dx.doi.org/10.1002%2Fibd.20870 Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy with ileal pouch-anal anastomosis; indications, technique, and management of common findings http://dx.doi.org/10.1002%2Fibd.20874 Appraisal of the pediatric ulcerative colitis activity index (PUCAI) http://dx.doi.org/10.1002%2Fibd.20867 Impact of perceived stigma on inflammatory bowel disease patient outcomes http://dx.doi.org/10.1002%2Fibd.20864 Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20861 Cervical dysplasia in immunosuppressed IBD women http://dx.doi.org/10.1002%2Fibd.20878 Cholestatic hepatitis, acute acalculous cholecystitis, and hemolytic anemia: primary Epstein-Barr virus infection under azathioprine http://dx.doi.org/10.1002%2Fibd.20856 Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease http://dx.doi.org/10.1002%2Fibd.20823 Acute hemorrhagic Crohn's disease controlled with infliximab http://dx.doi.org/10.1002%2Fibd.20840 Crohn's disease and radiation exposure: It's time we got our act together? http://dx.doi.org/10.1002%2Fibd.20836 A lump of coal for perianal fistulae? http://dx.doi.org/10.1002%2Fibd.20834 Diffuse colitis cystica profunda in a patient with ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20832 Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills http://dx.doi.org/10.1002%2Fibd.20830 Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)? http://dx.doi.org/10.1002%2Fibd.20841 Successful use of adalimumab in treating cutaneous metastatic Crohn's Disease: Report of a Case http://dx.doi.org/10.1002%2Fibd.20853 Endocarditis in Crohn's disease http://dx.doi.org/10.1002%2Fibd.20822 Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: Are we barking up the wrong tree? http://dx.doi.org/10.1002%2Fibd.20802 Bilateral parotidomegaly following anaphylaxis to infliximab http://dx.doi.org/10.1002%2Fibd.20801 Development of de novo celiac disease after restorative proctocolectomy and ileal pouch-anal anastomosism http://dx.doi.org/10.1002%2Fibd.20791 Case of linear IgA bullous dermatosis-involved ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20795 Clinical course of late-onset Crohn's disease http://dx.doi.org/10.1002%2Fibd.20789 Endoscopic healing should be a goal for everyone with ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20779 Girls connect: Effects of a support group for teenage girls with inflammatory bowel disease and their mothers http://dx.doi.org/10.1002%2Fibd.20775 Severe case of genital and perianal cutaneous Crohn's disease http://dx.doi.org/10.1002%2Fibd.20773 Association of "ulcerative appendicitis" and appendiceal adenocarcinoma http://dx.doi.org/10.1002%2Fibd.20790 Infliximab-induced reactivated Langerhan's cell histiocytosis in a patient with ulcerative colitis http://dx.doi.org/10.1002%2Fibd.20796 Mesenteric ischemia is a cause of resistance to treatment in IBD http://dx.doi.org/10.1002%2Fibd.20784 Preliminary results obtained with cefoperazone plus corticosteroids in the treatment of active Crohn's disease http://dx.doi.org/10.1002%2Fibd.20772 Esophageal ulcer of Crohn's disease: Disappearance in 1 week with infliximab http://dx.doi.org/10.1002%2Fibd.20769